Every case of essential thrombocythemia should be tested for the Philadelphia chromosome
Authors:
- 1 January 2004
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 78 (1) , 71-73
Abstract
Essential thrombocythemia (ET) and chronic myelogenous leukemia (CML) usually present with distinctive features. Citing experience with cases that overlap, the Polycythemia Vera Study Group recommends that negative tests for the Philadelphia chromosome be obtained before diagnosing ET. We describe two young women presenting with features absolutely typical for ET, including extreme thrombocytosis, no leukocytosis, no basophilia, no peripheral immature cells, and no splenomegaly. Severe thrombotic complications ensued: multiple cerebrovascular thromboemboli, pulmonary emboli, and miscarriage in one and myocardial infarction in the other. By 4 years, both developed leukocytosis, extreme basophilia, and circulating blasts, typical of accelerated CML. Cytogenetic studies were then performed, revealing the Philadelphia chromosome. Imatinib produced rapid clearing of blasts and basophils, but one woman later succumbed after allogeneic bone marrow transplant and the other has not achieved a major cytogenetic response. We conclude that CML can present in identical fashion as ET. The mandate for routine Philadelphia chromosome testing is magnified by the availability of targeted therapy and its greater efficacy in early stage disease. Am. J. Hematol. 78:71–73, 2005.Keywords
This publication has 7 references indexed in Scilit:
- ThrombocytosisNew England Journal of Medicine, 2004
- Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylateBlood, 2004
- Imatinib alone and in combination for chronic myeloid leukemiaSeminars in Hematology, 2003
- Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyBlood, 2002
- BCR-ABL transcripts may be detected in essential thrombocythemia but lack clinical significanceBlood, 2001
- Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosomeAmerican Journal of Hematology, 1988
- The Peripheral Blood in Chronic Granulocytic LeukaemiaScandinavian Journal of Haematology, 1977